Journal of Medicinal Chemistry · 2018 · 112 citations · 39 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsFunctional Group SubstitutionLipophilicity ModulationLipophilicity OptimizationMetabolic Stability OptimizationStructure-activity Relationship AnalysisDrug Candidate OptimizationFluorination ProcessesLipophilicity ReductionLog P OptimizationMedicinal Chemistry ApplicationsMetabolic Stability ModulationMolecular LipophilicityOptimization Of Drug-like Properties
-group of a perfluoroalkyl chain to a methyl group leads to a drastic reduction in lipophilicity. We also show that changing a C-F bond of a trifluoromethyl group, including when incorporated as part of a perfluoroalkyl group, to a C-Me group, leads to a reduction in log P, despite the resulting chain elongation. The observed lipophilicity trends were identified in fluorinated alkanol models and reproduced when incorporated in analogues of a drug candidate, and the metabolic stability of these motifs was demonstrated.
39
The Many Roles for Fluorine in Medicinal Chemistry
William K. Hagmann · Journal of Medicinal Chemistry · 2008 · 3.6K citations · Full text